A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia. Study co-author Jennifer Schneiderman, MD, discusses results, published in the <em>New England Journal of Medicine</em>.

A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia. Study co-author Jennifer Schneiderman, MD, discusses results, published in the New England Journal of Medicine.

Life-Changing Gene Therapy for Beta-Thalassemia Patients with Jennifer Schneiderman, MD

Breakthroughs is a podcast about groundbreaking research and the scientists leading these discoveries at Northwestern University Feinberg School of Medicine. We are driven by our mission to transform the practice of medicine and profoundly impact human health beyond the individual patient. We believe better answers only come from discovery.

Share Life-Changing Gene Therapy for Beta-Thalassemia Patients with Jennifer Schneiderman, MD

Sign up to save your podcasts

Life-Changing Gene Therapy for Beta-Thalassemia Patients with Jennifer Schneiderman, MD

Life-Changing Gene Therapy for Beta-Thalassemia Patients with Jennifer Schneiderman, MD

More shows like Breakthroughs

On the Media

The Insightful Leader

Freakonomics Radio

Hidden Brain

The New Yorker Radio Hour

Pod Save America

NorthwesternU

One Book, One Northwestern: The Podcast

Northwestern Intersections

Why Is This Happening? The Chris Hayes Podcast

The Peter Attia Drive

The Megyn Kelly Show

Huberman Lab

The Ezra Klein Show

We Can Do Hard Things

The Weekly Show with Jon Stewart

Explore Global Health with Rob Murphy, MD

Letters from an American

The Wirecutter Show